Skip to main content

Wilson Troy Edward's Form 4 filing

Kura Oncology, Inc.KURA · filed Nov 16, 2026

Accession no.
0001193125-26-464166
Filed
Nov 16, 2026, 7:45 PM ET
Trade date
Nov 13-16, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market purchases total $1.50M. It was filed 3 days after the trade.

This filing was later replaced by the amendment 0001193125-26-465499 (Nov 17, 2026). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wilson Troy EdwardCIK 0001589597Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2026Common StockPPurchaseAcquired+98,881$7.63F1+$754,462.03534,337Direct
Nov 16, 2026Common StockPPurchaseAcquired+101,119$7.42F2+$750,302.98635,456Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This transaction was executed in multiple trades at prices ranging from $7.47 to $7.79. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F2

This transaction was executed in multiple trades at prices ranging from $7.27 to $7.73. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)